78. Ms. B. S. Hastak and B. J. Ghiya ; Indian J. Heterocycl. Chem., 1992, 2, 133-135.79. P. A. Mehta and H. B. Naik ; Oriental J. Chem., 1998, 14(1), 159-160 ; Asian J.Chem.,1998, 10(4), 1017-8.80. E. T. Ogansyan et al. ; Khim. Farm. Zh., 25(8), 18(1991) ; Chem. Abstr., 1991,115, 247497n.81. S. Satoshi, N. Yasunori, U. Hiroki ; J. Med. Chem., 1993, 3904-9 (Eng.) ; Chem.Abstr., 1994, 120,133956j.82. Y. Satomi ; Ind. J. Cancer, 1993, 55(3), 506 ; Chem. Abstr., 1994, 120, 208071.83. R. J. Auto et al.; J. Clin. Biochem. Nutr., 1994, 17(2), 73 ; Chem. Abstr., 1995,123, 122487x.84. Li Rongshi, Chen. Xiawa., Gong Baogung, Qominguez, Jose N. et al.; J. Med.Chem. ,1995, 38(26), 5031-7; Chem. Abstr., 1996, 124, 232f.85. G. Zongru, H. Rui ; Chem. Abstr., 1996, 125, 10376r.86. F. S. Nielsen, S. B. Chirstensen; J. Med. Chem., 1998, 41, 4819-4832.87. Nissan Chemical Industries ; Chem. Abstr., 1983, 98, 178947a.88. R. Seele et al.; Eur. Pat. Appl. Ep., 1989, 337, 198(Cl C07D,249/08); Chem.Abstr., 1990, 113, 178990s.89. Tashio Pharmaceutical Co. Ltd.; Chem. Abstr., 1984, 101, 54722j.90. H. Serre, J. Rey and J. p. tarayre ; Fr. Demande, 2, 377, 201 (C1 A 61 K 37/48);Chem. Abstr., 1979, 91, 9494a.91. A. E. Vanstone, G. K. Maile and L. K. Nalbantoglu; Ger. Offen. 1986, DE 3, 537,207( C1. 07c-65/40); Chem. Abstr. 1987, 106, 49778f.92. K.. Bowden, P. A. Dal and C. K. Shah; J. Med. Res. Synop., 1990, 12, 2801 ;Chem. Abstr. 1991, 114, 160570m.93. Y. Inamori et al. ; Chem. Pharm. Bull., 39(6), 1604,(1991) ; Chem. Abstr., 1991,115, 105547c.94. V. M. Gaurav and D. B. Ingle ; Indian J. Chem., 1986, 25B, 868 ; Chem. Abstr.,1987, 107, 3932h.95. A. K. Pedersen and G. A. Fitz Gerald ; J. Pharm. Sci., 74(2), 188(1985); Chem.Abstr., 1985, 103, 87592m.96. D. Binder, C. R. Noe, W. Holzer and B. Rosenwirth ; Arch. Pharm. 1985, 318(1), 48;Chem. Abstr., 1985, 102, 149025u.97. M. R. Bell ; US Appl., 1984, 637, 931 ; Chem. Abstr., 1990, 113, 211828t.166References…..
98. Ni Liming, K. J. Worsencrott, M. D. Weingarten, C. Q.. Meng. J. A. Sikorski ; U. S.US. WO. 02, 2002, 41336 ; Chem. Abstr., 2003, 139, 85160.99. K. Kumar Srinivas, E. Hanger, C. Pehit, H. Gurulingoppal, N. E. Davidson, S.R.Khan ; J. Med. Chem., 2003, 46(14), 2813-15 ; Chem. Abstr., 2003, 139, 117464.100. Ko Horng-Huey, Tsao Lo- Ti, Yo Kum- Lung, Cheng-Tsung, Wong J. P., Lin C. N.;Bioorg. & Med. Chem., 2003, 11(1), 105-111 ; Chem. Abstr., 2003, 139, 30144.101. Nakahara Kazuhiko, Torakoontiwakon G., Kaneyama M. , Ono Hiroshi, YoshidaMitsuru ; Jpn. Kokai Tokkyo Koho JP 03, 2003, 040829 ; Chem. Abstr., 2003,138, 158753.102. Lin Yuh-Meei, Zhou Yasheen, Flavin M. T. Zhou L. M. Nie, W., Cheng, F. C. ;Bioorg. & Med. Chem., 10(8), 2795-2802(2002) ; Chem. Abstr., 2003, 138, 66146.103. E. Bombardelli, V. Piero ; PCT Int. Appl. WO 98, 58, 913 ; Chem. Abstr., 1999,130, 95382r.104. S. Elichi, K. Koji ; PCT Int. Appl. WO 99, 61, 403 ; Chem. Abstr., 2000, 132,12199d.105. B. B. Kalashnikov, I. P. Kalashnikov ; Russ. J. Gen. Chem., 1998 ; Chem. Abstr.,1994, 130, 296596n.106. S. Satoshi, N. Yasunori, V. Hiroki ; J. Med. Chem., 1993, 3904-9 (Eng.); Chem.Abstr., 1994, 120, 133956j.107. P. B. Walavalkar, S. Pednekar ; J. Heterocycl. Chem., 1999 ; Chem. Abstr., 1999,131, 257517p.108. O. Toru, O. Yoshihito, S. Shaji ; Chem. Abstr., 2000, 132, 22752t.109. J. R. Dimmock, M. Elisk ; U. S. US 6, 017, 933 ; Chem. Abstr., 2000, 132, 107880n.110. T. M. Abdet Rahman ; Bull. Chim. Farm. 1998, ; Chem. Abstr., 2000, 132, 93276h.111. B. P. Das, D. N. Chowdhary, K. Ghosh, G. K. Das; Environ and Ecolo., 2002,20(3), 649-55; Chem. Abstr., 2003, 139, 129387.112. Kim Min-Young, Park B. Y., Kim K. M., Sung N. D. Myung P. K. ; PCT Int. Appl. WO02 KR 2031 CA 61K031-03 (2002); Chem. Abstr., 2003, 138, 368613.113. M. Styanarayana and P. Tiwari, Bioorg. Med. Chem., 2004, 12(5), 883-889.114. S.R. Modi and H. B. Naik ; Orient J. Chem., 1994, 10(1), 85-6 ; Chem. Abstr.,1995, 112, 81186c.115. A. Attia, O. J. Abdetsulan, Abo-Ahalca ; Egypt J. Chem., 1995 ; Chem. Abstr.,1996, 125, 10570z.167References…..
- Page 3:
The Sarvodaya Education Society’s
- Page 6 and 7:
selfless help, moral support and gu
- Page 9 and 10:
Introduction and Spectral studies .
- Page 11 and 12:
“STUDIES ON SOME HETEROCYCLICENTI
- Page 13 and 14:
Pyrimidine derivatives have been pr
- Page 15 and 16:
Isoxazole derivative synthesized by
- Page 17 and 18:
“STUDIES ON SOMEHETEROCYCLIC ENTI
- Page 19 and 20:
(b) Pharmacokinetics: It is derived
- Page 21 and 22:
(C) Drug DevelopmentMany natural pr
- Page 23 and 24:
The process of drug design is exten
- Page 25 and 26:
(l) Non steroidal anti-inflammatory
- Page 27 and 28:
INTRODUCTIONThe aza-indolizine cont
- Page 29 and 30:
PHARMACEUTICAL IMPORTANTMuch resear
- Page 31 and 32:
Compd. R 1 R 2 R 3a :- H 7-Me-6,8-B
- Page 33 and 34:
S. Kristjan, Gudmundsson and A. Bra
- Page 35 and 36:
STUDIES ON IMIDAZOPYRIDINE DERIVATI
- Page 37 and 38:
(a) Chalcones with monoethanolamine
- Page 39 and 40:
Das B.P. et al. 111 have found that
- Page 41 and 42:
Furthermore, Alcaraz M.J, et al. 13
- Page 43 and 44:
REACTION SCHEMECl+ClOClOClClCH 3NH
- Page 45 and 46:
Instrument : SHIMADZU FTIR 8400 Spe
- Page 47 and 48:
SignalNo.SignalPosition(δppm)Relat
- Page 49 and 50:
ANTIMICROBIAL ACTIVITYProducts : Ch
- Page 51 and 52:
The reaction mixture was poured on
- Page 53 and 54:
TABLE NO.- 1A BIOLOGICAL SCREENING
- Page 55 and 56:
PART-IISTUDIES ON PYRIMIDINES
- Page 57 and 58:
The self consistent (pi)electron de
- Page 59 and 60:
class of dye viz. trichloro pyrimid
- Page 61 and 62:
ability to cleave nucleic acid targ
- Page 63 and 64:
SSNHNHoONOoONOo(11) (12)oOHThe Pyri
- Page 65 and 66:
called ABPP or bropirimine(2-amino-
- Page 67 and 68:
acid so that it could be utilized f
- Page 69 and 70:
have reported the 5-substitutedfuro
- Page 71 and 72:
maturation of the viral mRNA molecu
- Page 73 and 74:
Nevertheless, these compounds const
- Page 75 and 76:
OHHNCH 3Cl(CH 2 )nSNNR 2R 1N H 2NSR
- Page 77 and 78:
SECTION-ISTUDIES ONOXOPYRIMIDINES
- Page 79 and 80:
PHARMACEUTICAL IMPORTANCEIn recent
- Page 81 and 82:
REACTION SCHEMECH 3NNCHOCl10% KOH R
- Page 83 and 84:
INSTRUMENT :SHIMADZU FTIR 8400 Spec
- Page 85 and 86:
SignalNo.SignalPosition(δppm)Relat
- Page 87 and 88:
EXPERIMENTALSynthesis and therapeut
- Page 89 and 90:
TABLE NO.- 2(IB)PHYSICAL CONSTANTS
- Page 91 and 92:
INTRODUCTIONThiopyrimidine derivati
- Page 93 and 94:
H 3 COHNRH 3 CH 3 CNHS( IV ) R = ar
- Page 95 and 96:
SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 97 and 98:
IR SPECTRAL STUDIES OF 6-(2-(4-CHLO
- Page 99 and 100:
NMR SPECTRAL STUDIES OF 6-(2-(4-CHL
- Page 101 and 102:
MASS SPECTRAL STUDIES OF 6-(2-(4-CH
- Page 103 and 104:
[F] Antimicrobial activity of 6-(2-
- Page 105 and 106:
SECTION-IIISTUDIES ONAMINOPYRIMIDIN
- Page 107 and 108:
ArCHO+ArCOCH3NaOHMethanolR R 1ONaOH
- Page 109 and 110:
SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 111 and 112:
IR SPECTRAL STUDIES OF 4-(2-(4-CHLO
- Page 113 and 114:
NMR SPECTRAL STUDIES OF 4-(2-(4-CHL
- Page 115 and 116:
MASS SPECTRAL STUDIES OF 4-(2-(4-CH
- Page 117 and 118:
[F] Antimicrobial activity of 4-(2-
- Page 119 and 120:
PART-IIISTUDIES ONCYCLOHEXENONES
- Page 121 and 122:
2. Michael addition of chalcone wit
- Page 123 and 124:
Rheinheimer J. et al. 381have synth
- Page 125 and 126:
SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 127 and 128:
IR SPECTRAL STUDIES OF ETHYL-6-(2-(
- Page 129 and 130:
NMR SPECTRAL STUDIES OF ETHYL-6-(2-
- Page 131 and 132:
MASS SPECTRAL STUDIES OF ETHYL-6-(2
- Page 133 and 134:
Antimicrobial testing was carried o
- Page 135 and 136:
PART-IVSTUDIES ON PYRAZOLINES
- Page 137 and 138: H 2 C= CHCN + Ar - NHNH 2NArN(3) 2
- Page 139 and 140: PHARMACEUTICAL IMPORTANCE :2- Pyraz
- Page 141 and 142: Kadu et al. 424 and antimicrobial b
- Page 143 and 144: REACTION SCHEMECH 3NNClCHO10% KOHRO
- Page 145 and 146: Instrument : SHIMADZU FTIR 8400 Spe
- Page 147 and 148: SignalNo.SignalPosition(δppm)Relat
- Page 149 and 150: EXPERIMENTALSynthesis and therapeut
- Page 151 and 152: TABLE NO.- 4(B)PHYSICAL CONSTANTS O
- Page 153 and 154: INTRODUCTION:Isoxazole come under t
- Page 155 and 156: PHARMACEUTICAL IMPORTANCE :Isoxazol
- Page 157 and 158: SYNTHESISAND THERAPEUTIC EVALUATION
- Page 159 and 160: IR SPECTRAL STUDIES OF 2-(4-CHLOROP
- Page 161 and 162: NMR SPECTRAL STUDIES OF 2-(4-CHLORO
- Page 163 and 164: MASS SPECTRAL STUDIES OF 2-(4-CHLOR
- Page 165 and 166: [F]Antimicrobial activity of 2-(4-c
- Page 167 and 168: PART-VISTUDIES ON OXIRANES
- Page 169 and 170: ( iii ) Epoxidation can also been c
- Page 171 and 172: Moreover, Nomura Yutaka et al. 487
- Page 173 and 174: SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 175 and 176: IR SPECTRAL STUDIES OF (3-(2-(4-CHL
- Page 177 and 178: NMR SPECTRAL STUDIES OF (3-(2-(4-CH
- Page 179 and 180: MASS SPECTRAL STUDIES OF (3-(2-(4-C
- Page 181 and 182: [F] Antimicrobial activity of (3-(2
- Page 184 and 185: 1. J. A. Joule and K. Mills; Hetero
- Page 186 and 187: 37. James J. Kaminski, D. G. perkin
- Page 190 and 191: 116. V. R. Mudalir and V. Joshi ; I
- Page 192 and 193: 150. S. Inoue, A. J. Saggimoto and
- Page 194 and 195: 197. S. S. Bahekar, D. B. Shinde; A
- Page 196 and 197: 238. A. Kreutzberger and M. Sellhei
- Page 198 and 199: 280. See, for example, W. H. Prusof
- Page 200 and 201: 326. C. W. Whitehead and J. J. Trav
- Page 202 and 203: 366. Nagarjan K., Shenoy S. J.; Ind
- Page 204 and 205: 396. Ausra Voskiene,Vytautas Mickev
- Page 206 and 207: 432. Solankee Sejal; Prajapati Yoge
- Page 208 and 209: 463. Mishra Ashutosh ; Jain Sanmati
- Page 210 and 211: 496. Kaneko Mashami, Saitoh Yutaka,
- Page 212 and 213: CH 3CH 3NNClNNClORHNONRRRC 6 H 5 -
- Page 214 and 215: CH 3CH 3NNClNNClEtOOCORHNNRRRC 6 H